COLLABORATIVE FOR EVIDENCE BASED MEDICINES
LIVE

Serial Number

99822974

Owner

Hertig Healthcare Advising, LLC

Attorney

Abe Jentry Shanehsaz

Filing Date

May 14, 2026

Add to watchlist:

No watchlists yet
View on USPTO

COLLABORATIVE FOR EVIDENCE BASED MEDICINES Trademark

Serial Number: 99822974

COLLABORATIVE FOR EVIDENCE BASED MEDICINES is a trademark filed by Hertig Healthcare Advising, LLC on May 14, 2026. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Hertig Healthcare Advising, LLC

6664 Cornell Ave.
Indianapolis, IN 46220

Entity Type: 16

Trademark Details

Filing Date

May 14, 2026

Registration Date

Not Registered

Goods & Services

Providing medical research information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Providing scientific information, news, and commentary in the field of medicines, pharmaceutical safety and FDA approved drugs, dangers relating to unsafe compounding practices, unregulated medicines, and safely obtaining pharmaceutical drugs

Providing medical information; Providing health information; Providing medical information in the field of medicines, pharmaceutical safety and FDA approved drugs, dangers relating to unsafe compounding practices, unregulated medicines, and safely obtaining pharmaceutical drugs; Providing news and information in the field of medicine

Commercial lobbying services; Promoting public awareness of medicines, pharmaceutical safety and FDA approved drugs, dangers relating to unsafe compounding practices, unregulated medicines, and safely obtaining pharmaceutical drugs by means of public advocacy; Association services, namely, promoting the interests of pharmacies, pharmacists, individuals obtaining pharmaceuticals, patients and their advocates, public health organizations, pharmaceutical companies, boards of pharmacy, and other health care providers

Education services, namely, providing classes, seminars, workshops in the field of medicines, pharmaceutical safety and FDA approved drugs, dangers relating to unsafe compounding practices, unregulated medicines, and safely obtaining pharmaceutical drugs; Development and dissemination of printed educational materials of others in the field of medicines, pharmaceutical safety and FDA approved drugs, dangers relating to unsafe compounding practices, unregulated medicines, and safely obtaining pharmaceutical drugs

Expert witness services in legal matters in the field of medicines, pharmaceutical safety, FDA approved drugs, dangers relating to unsafe compounding practices, unregulated medicines, and safely obtaining pharmaceutical drugs

Filing History

APPLICATION FILING RECEIPT MAILED
May 14, 2026 MAFR
NEW APPLICATION ENTERED
May 14, 2026 NWAP